Status:
COMPLETED
Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events
Lead Sponsor:
University Health Network, Toronto
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The goal of this study is to identify any side effects caused by the implanting of markers via the rectum. The investigators will also try to determine if any other factors (such as the position of th...
Detailed Description
Precise localisation of target organs has become increasingly important with the routine use of steep dose gradients from conformal and intensity modulated radiotherapy. This is particularly challengi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Have biopsy confirmed prostate cancer (any risk category)
- Have 3 intra-prostatic markers inserted at PMH prior to radiotherapy
- Be willing to provide written informed consent
- Be willing to complete the adverse event questionnaires
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00923416
Start Date
September 1 2008
End Date
November 1 2010
Last Update
December 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9